Literature DB >> 32452411

An essential N-terminal serine-rich motif in the AAV VP1 and VP2 subunits that may play a role in viral transcription.

Tawana M Robinson1, Michelle L Ho2, Brian Wahlig2, Veronica Gough2, Anton Banta2, Kiara Reyes Gamas2, Byunguk Kang2, Esther Lee2, Weitong Chen3, Junghae Suh4.   

Abstract

Adeno-associated virus (AAV) is one of the most researched, clinically utilized gene therapy vectors. Though clinical success has been achieved, transgene delivery and expression may be hindered by cellular and tissue barriers. Understanding the role of receptor binding, entry, endosomal escape, cytoplasmic and nuclear trafficking, capsid uncoating, and viral transcription in therapeutic efficacy is paramount. Previous studies have shown that N-terminal regions of the AAV capsid proteins are responsible for endosomal escape and nuclear trafficking, however the mechanisms remain unknown. We identified a highly-conserved three-residue serine/threonine (S/T) motif in the capsid N-terminus, previously uncharacterized in its role in intracellular trafficking and transduction. Using alanine scanning mutagenesis, we found S155 and the flanking residues, D154 and G158, are essential for AAV2 transduction efficiency. Remarkably, specific capsid mutants show a 5 to 9-fold decrease in viral mRNA transcripts, highlighting a potential role of the S/T motif in transcription of the viral genome.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAV; Capsid; Gene therapy vectors; Intracellular trafficking; Transduction

Mesh:

Substances:

Year:  2020        PMID: 32452411      PMCID: PMC7395364          DOI: 10.1016/j.virol.2020.04.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry.

Authors:  Sarah Murray; Carol L Nilsson; Joan T Hare; Mark R Emmett; Andrei Korostelev; Heather Ongley; Alan G Marshall; Michael S Chapman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.

Authors:  Ziying Yan; Roman Zak; Yulong Zhang; John F Engelhardt
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.

Authors:  Nishanth Gabriel; Sangeetha Hareendran; Dwaipayan Sen; Rupali A Gadkari; Govindarajan Sudha; Ruchita Selot; Mansoor Hussain; Ramya Dhaksnamoorthy; Rekha Samuel; Narayanaswamy Srinivasan; Alok Srivastava; Giridhara R Jayandharan
Journal:  Hum Gene Ther Methods       Date:  2013-03-15       Impact factor: 2.396

4.  High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.

Authors:  David M Markusic; Roland W Herzog; George V Aslanidi; Brad E Hoffman; Baozheng Li; Mengxin Li; Giridhara R Jayandharan; Chen Ling; Irene Zolotukhin; Wenqin Ma; Sergei Zolotukhin; Arun Srivastava; Li Zhong
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

5.  Production and characterization of adeno-associated viral vectors.

Authors:  Joshua C Grieger; Vivian W Choi; R Jude Samulski
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.

Authors:  Anne Girod; Christiane E Wobus; Zoltán Zádori; Martin Ried; Kristin Leike; Peter Tijssen; Jürgen A Kleinschmidt; Michael Hallek
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

7.  Adeno-associated virus capsid proteins may play a role in transcription and second-strand synthesis of recombinant genomes.

Authors:  Maxim Salganik; Fikret Aydemir; Hyun-Joo Nam; Robert McKenna; Mavis Agbandje-McKenna; Nicholas Muzyczka
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

8.  Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.

Authors:  Li Zhong; Baozheng Li; Cathryn S Mah; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Mario Cooper; Roland W Herzog; Irene Zolotukhin; Kenneth H Warrington; Kirsten A Weigel-Van Aken; Jacqueline A Hobbs; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

9.  Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression.

Authors:  Li Zhong; Baozheng Li; Giridhararao Jayandharan; Cathryn S Mah; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Roland W Herzog; Kirsten A Weigel-Van Aken; Jacqueline A Hobbs; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava
Journal:  Virology       Date:  2008-10-02       Impact factor: 3.616

10.  Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity.

Authors:  Melissa Bartel; David Schaffer; Hildegard Büning
Journal:  Front Microbiol       Date:  2011-10-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.